{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:09:22Z","timestamp":1784268562234,"version":"3.55.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dematiaceous fungal infections are frequently encountered in clinical practice with no unified treatment. Drug combination reduces drug resistance, and repurposed clinical drugs as synergists show promise in aiding azoles against phaeohyphomycosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To investigate the synergistic antifungal effects of docetaxel (DTX) in combination with azoles against dematiaceous fungi and\n                      <jats:italic>Aspergillus niger<\/jats:italic>\n                      , as well as their impact on efflux pump activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      CLSI M38-A2 microbroth dilution method was used to detect fractional inhibitory concentration index of DTX with posaconazole (POS), itraconazole (ITC), voriconazole (VOR), and isavuconazole (ISA) against 43 fungi (including 24 strains of\n                      <jats:italic>Exophiala dermatitidis<\/jats:italic>\n                      , 7 strains of\n                      <jats:italic>Exophiala alcalophila<\/jats:italic>\n                      , 3 strains of\n                      <jats:italic>Fonsecaea pedrosoi<\/jats:italic>\n                      , 1 strain of\n                      <jats:italic>Fonsecaea monophora<\/jats:italic>\n                      , 1 strain of\n                      <jats:italic>Exophiala verrucosa<\/jats:italic>\n                      and 7 strains of\n                      <jats:italic>Aspergillus niger<\/jats:italic>\n                      ). Rhodamine 6G transport efficiency and transcriptional variations of efflux pump genes were determined in strains treated with POS alone or POS combined with DTX.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      DTX alone had no antifungal activity. 30\/43 (69.8%) strains showed synergy with POS (87.5%\n                      <jats:italic>E. dermatitidis<\/jats:italic>\n                      , 100%\n                      <jats:italic>A. niger<\/jats:italic>\n                      ). 7 (16.3%), 3 (7.0%) and 1 (2.3%) strains showed synergy with ITC, VOR and ISA. For strains with POS synergism, DTX treatment significantly suppressed efflux activity and modified the transcription of efflux pump genes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The combined scheme of DTX and POS can significantly reduce the minimum inhibitory concentration of POS and show synergistic antifungal activity, especially significant against\n                      <jats:italic>E. dermatitidis<\/jats:italic>\n                      and\n                      <jats:italic>A. niger<\/jats:italic>\n                      . Its mechanism of action may be related to the reduction of efflux pump activity.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1832946","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:45:40Z","timestamp":1784267140000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro study on synergistic antifungal effects of docetaxel combined with azoles against dematiaceous fungi and Aspergillus niger"],"prefix":"10.3389","volume":"17","author":[{"given":"Heng","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Dermatology, Hubei Provincial Clinical Research Center for Diagnosis and Therapeutics of Pathogenic Fungal Infection, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hubei Provincial Clinical Research Center for Diagnosis and Therapeutics of Pathogenic Fungal Infection, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Yangtze University","place":["Jingzhou, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Yangtze University","place":["Jingzhou, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Yangtze University","place":["Jingzhou, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Yangtze University","place":["Jingzhou, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Yangtze University","place":["Jingzhou, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hubei Provincial Clinical Research Center for Diagnosis and Therapeutics of Pathogenic Fungal Infection, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1002\/jcp.29339","article-title":"PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells","volume":"235","author":"Afsharzadeh","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"10781","DOI":"10.1021\/acs.jmedchem.4c02922","article-title":"Exploring long arm amide-linked side chains in the design of antifungal azole inhibitors of sterol 14alpha-demethylase (cyp51)","volume":"68","author":"Alsulaimany","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2165\/00003088-200645030-00002","article-title":"Clinical pharmacokinetics of docetaxel: recent developments","volume":"45","author":"Baker","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jof7020068","article-title":"Directed mutational strategies reveal drug binding and transport by the mdr transporters of Candida albicans","volume":"7","author":"Banerjee","year":"2021","journal-title":"J. Fungi"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0169-409x(01)00196-x","article-title":"Chemically modified chitosans as enzyme inhibitors","volume":"52","author":"Bernkop-Schnurch","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1128\/AAC.01252-16","article-title":"A combination fluorescence assay demonstrates increased efflux pump activity as a resistance mechanism in azole-resistant vaginal Candida albicans isolates","volume":"60","author":"Bhattacharya","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jof9060662","article-title":"Etiology, predisposing factors, clinical features and diagnostic procedure of otomycosis: a literature review","volume":"9","author":"Bojanovic","year":"2023","journal-title":"J. Fungi"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"100717","DOI":"10.1016\/j.mmcr.2025.100717","article-title":"Deep cutaneous phaeohyphomycosis caused by Cladophialophora boppii: a case report","volume":"49","author":"Cavens","year":"2025","journal-title":"Med. Mycol. Case Rep."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fphys.2014.00197","article-title":"Mfs multidrug transporters in pathogenic fungi: do they have real clinical impact?","volume":"5","author":"Costa","year":"2014","journal-title":"Front. Physiol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3390\/cells12222655","article-title":"Molecular mechanisms associated with antifungal resistance in pathogenic Candida species","volume":"12","author":"Czajka","year":"2023","journal-title":"Cells"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/pros.23182","article-title":"Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation","volume":"76","author":"de Morree","year":"2016","journal-title":"Prostate"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1186\/s12885-015-1689-8","article-title":"Frequent down-regulation of abc transporter genes in prostate cancer","volume":"15","author":"Demidenko","year":"2015","journal-title":"BMC Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/jac\/dkt075","article-title":"The cdr1b efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus","volume":"68","author":"Fraczek","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1007\/s42770-021-00611-2","article-title":"Expression of f-actin and \u03b2-tubulin genes in free mycelia and robust biofilms of the filamentous fungus Aspergillus niger","volume":"52","author":"Guimar Es","year":"2021","journal-title":"Brazilian J. Microbiol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3892\/mco.2018.1770","article-title":"Prognostic significance of foxm1 in oral squamous cell carcinoma patients treated by docetaxel-containing regimens","volume":"10","author":"Harada","year":"2019","journal-title":"Mol. Clin. Oncol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1186\/s12885-024-12653-4","article-title":"Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (paradise-1): a phase i trial","volume":"24","author":"Hirata","year":"2024","journal-title":"BMC Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e1787764174","DOI":"10.1073\/pnas.2507203122","article-title":"Cdkn1b (p27\/kip1) enhances drug-tolerant persister ctcs by restricting polyploidy following mitotic inhibitors","volume":"122","author":"Horwitz","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/1758834012449685","article-title":"Overcoming docetaxel resistance in prostate cancer: a perspective review","volume":"4","author":"Hwang","year":"2012","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"103938","DOI":"10.1016\/j.fgb.2024.103938","article-title":"Update on the structure and function of Candida albicans drug efflux protein, Cdr1","volume":"175","author":"Ibe","year":"2024","journal-title":"Fungal Genet. Biol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e530222","DOI":"10.1128\/spectrum.05302-22","article-title":"In vitro and in vivo evaluation of synergistic effects of everolimus in combination with antifungal agents on Exophiala dermatitidis","volume":"11","author":"Jia","year":"2023","journal-title":"Microbiol. Spectrum"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3390\/biomedicines10051187","article-title":"Nanoparticles loaded with docetaxel and resveratrol as an advanced tool for cancer therapy","volume":"10","author":"Jurczyk","year":"2022","journal-title":"Biomedicine"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1158\/1535-7163.MCT-13-0743","article-title":"Masitinib antagonizes atp-binding cassette subfamily c member 10-mediated paclitaxel resistance: a preclinical study","volume":"13","author":"Kathawala","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1080\/21505594.2019.1596504","article-title":"Exophiala dermatitidis: key issues of an opportunistic fungal pathogen","volume":"10","author":"Kirchhoff","year":"2019","journal-title":"Virulence"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"31543","DOI":"10.1074\/jbc.271.49.31543","article-title":"Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter pdr5p","volume":"271","author":"Kolaczkowski","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.tips.2016.03.003","article-title":"Improving taxane-based chemotherapy in castration-resistant prostate cancer","volume":"37","author":"Kroon","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e32523","DOI":"10.1128\/spectrum.00325-23","article-title":"The C(2)H(2)-type transcription factor ZFPA, coordinately with CRZA, affects azole susceptibility by regulating the multidrug transporter gene ATRF in Aspergillus fumigatus","volume":"11","author":"Li","year":"2023","journal-title":"Microbiol. Spectrum"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"140226","DOI":"10.1016\/j.ijbiomac.2025.140226","article-title":"Targeting tubulin protein to combat fungal disease: design, synthesis, and its new mechanistic insights of benzimidazole hydrazone derivatives","volume":"300","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"869461","DOI":"10.3389\/fphar.2022.869461","article-title":"Itraconazole reverts ABCB1-mediated docetaxel resistance in prostate cancer","volume":"13","author":"Lima","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative pcr and the 2(\u2212delta delta c(t)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.2165\/00003495-200565170-00007","article-title":"Docetaxel: a review of its use in metastatic breast cancer","volume":"65","author":"Lyseng-Williamson","year":"2005","journal-title":"Drugs"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/bs.acr.2015.03.001","article-title":"Exploitation of the androgen receptor to overcome taxane resistance in advanced prostate cancer","volume":"127","author":"Martin","year":"2015","journal-title":"Adv. Cancer Res."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1128\/EC.00171-13","article-title":"Contributions of Aspergillus fumigatus atp-binding cassette transporter proteins to drug resistance and virulence","volume":"12","author":"Paul","year":"2013","journal-title":"Eukaryot. Cell"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"105807","DOI":"10.1016\/j.ijantimicag.2019.09.011","article-title":"Azole resistance mechanisms in aspergillus: update and recent advances","volume":"55","author":"Perez-Cantero","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa041318","article-title":"Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer","volume":"351","author":"Petrylak","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0093-7754(01)90148-4","article-title":"Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer","volume":"28","author":"Pienta","year":"2001","journal-title":"Semin. Oncol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fcimb.2016.00136","article-title":"The transcriptome of Exophiala dermatitidis during ex-vivo skin model infection","volume":"6","author":"Poyntner","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3389\/fmicb.2018.01457","article-title":"Transcriptome study of an Exophiala dermatitidis pks1 mutant on an ex vivo skin model: is melanin important for infection?","volume":"9","author":"Poyntner","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1128\/CMR.00032-16","article-title":"Chromoblastomycosis","volume":"30","author":"Queiroz-Telles","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"103070","DOI":"10.1016\/j.jiph.2025.103070","article-title":"Comparative overview of Aspergillus fumigatus, A. Flavus, and A. niger: pathogenicity, resistance, and public health significance","volume":"19","author":"Rafique","year":"2026","journal-title":"J. Infect. Public Health"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.idc.2006.06.004","article-title":"Phaeohyphomycosis","volume":"20","author":"Revankar","year":"2006","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1146\/annurev-micro-030117-020345","article-title":"Molecular evolution of antifungal drug resistance","volume":"71","author":"Robbins","year":"2017","journal-title":"Ann. Rev. Microbiol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"26213","DOI":"10.1038\/srep26213","article-title":"Triazole resistance mediated by mutations of a conserved active site tyrosine in fungal lanosterol 14alpha-demethylase","volume":"6","author":"Sagatova","year":"2016","journal-title":"Sci. Rep."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/pros.20991","article-title":"Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs","volume":"69","author":"Sanchez","year":"2009","journal-title":"Prostate"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/pros.21398","article-title":"Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins","volume":"71","author":"Sanchez","year":"2011","journal-title":"Prostate"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1128\/AAC.49.2.668-679.2005","article-title":"Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance","volume":"49","author":"Sanguinetti","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/IJN.S15500","article-title":"Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation","volume":"6","author":"Saremi","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1128\/AAC.00053-14","article-title":"Intrapulmonary posaconazole penetration at the infection site in an immunosuppressed murine model of invasive pulmonary aspergillosis receiving oral prophylactic regimens","volume":"58","author":"Seyedmousavi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e190324","DOI":"10.1128\/jcm.01903-24","article-title":"Establishment of epidemiological cutoff values for Fonsecaea pedrosoi, the primary etiologic agent of chromoblastomycosis, and eight antifungal medications","volume":"63","author":"Smith","year":"2025","journal-title":"J. Clin. Microbiol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e12562","DOI":"10.1371\/journal.pntd.0012562","article-title":"A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group","volume":"18","author":"Smith","year":"2024","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/acs.molpharmaceut.0c00432","article-title":"Ph-sensitive nanoparticles codelivering docetaxel and dihydroartemisinin effectively treat breast cancer by enhancing reactive oxidative species-mediated mitochondrial apoptosis","volume":"18","author":"Tao","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.simyco.2017.01.001","article-title":"Exploring the genomic diversity of black yeasts and relatives (chaetothyriales, ascomycota)","volume":"86","author":"Teixeira","year":"2017","journal-title":"Stud. Mycol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1158\/0008-5472.CAN-12-0783","article-title":"Androgen receptor on the move: boarding the microtubule expressway to the nucleus","volume":"72","author":"Thadani-Mulero","year":"2012","journal-title":"Cancer Res."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/s1359-6446(01)02149-3","article-title":"Targeted taxane therapy for cancer","volume":"7","author":"Whelan","year":"2002","journal-title":"Drug Discov. Today"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.idc.2015.10.007","article-title":"Dematiaceous molds","volume":"30","author":"Wong","year":"2016","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"8281","DOI":"10.1021\/acs.orglett.5c02469","article-title":"Nitrite-catalyzed stereoselective bromocyclization to access tetrahydrofuran scaffolds under batch and flow: an economic and sustainable approach to gram-scale total synthesis of posaconazole","volume":"27","author":"Xiao","year":"2025","journal-title":"Org. Lett."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.13346\/j.mycosystema.250029","article-title":"Function of an efflux pump-encoding gene and its protein in Exophiala dermatitidis","author":"Yuan","year":"2025","journal-title":"Mycosystema"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e318424","DOI":"10.1128\/spectrum.03184-24","article-title":"In vitro interactions of berbamine hydrochloride and azoles against Aspergillus fumigatus","volume":"13","author":"Zhang","year":"2025","journal-title":"Microbiol. Spectrum"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1832946\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:45:43Z","timestamp":1784267143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1832946\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":57,"alternative-id":["10.3389\/fmicb.2026.1832946"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1832946","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"1832946"}}